It is estimated that the majority of breast cancer subtypes are responsive to sex steroid hormones (particularly estrogen and progesterone) due to their expression of classic estrogen receptors (ERs), classic progesterone receptors (nPRs), or both, and are therefore termed hormone-responsive cancers [4,5]. The gene discussed is ESR1; the disease is breast cancer.